A 350-Study Review Questions Whether More Protein Really Means Healthier Aging

Protein is now marketed in cereal, coffee, and water. A new review of more than 350 studies argues that for most sedentary adults, that trend may be running past what the science supports.

A 350-Paper Review Puts the Protein Boom Under Scrutiny

The review, led by Bailey A. Knopf and Dudley W. Lamming of the University of Wisconsin-Madison, was published July 31 in the Cell Press journal Cell Press Blue. It draws on more than 350 previously published papers spanning humans, mice, flies, and yeast to examine how reducing protein intake affects metabolism and aging. Lamming, the corresponding author, said the muscle-building benefits of protein for active people are well established, but added that most people are sedentary, and "many people are likely consuming more protein than they actually need, which probably has negative health consequences." The review does not report new experiments; it synthesizes existing evidence, and its conclusions carry the weight — and the limits — of a literature synthesis rather than a controlled trial.

FGF21 and the Biological Pathway Linked to Protein Restriction

The review's central mechanistic thread runs through fibroblast growth factor 21, or FGF21, a hormone that rises when protein intake falls. According to Cell Press's summary, elevated FGF21 has been tied to higher energy expenditure, improved blood sugar regulation, and reduced inflammation. Mouse studies cited in the review found that animals with elevated FGF21 levels lived longer than typical mice, with a stronger effect observed in males than in females. Human studies show the same directional hormone response: lower protein intake raises FGF21 in people as well as in rodents. The review frames this as one plausible route by which protein restriction could influence lifespan, though it stops short of claiming the mechanism is fully proven in humans.

The RDA Gap Behind the Protein-Marketing Boom

Part of what the review is reacting to is a genuine shift in official guidance. The original U.S. recommended dietary allowance for protein has long stood near 0.8 grams per kilogram of body weight. Newer dietary guidance, as described in Cell Press's account of the paper, calls for 1.2 to 1.6 grams per kilogram daily — nearly double the earlier figure. Speaking separately to ABC News, Lamming suggested sedentary individuals might reasonably stay closer to the original 0.8 g/kg figure, while clarifying this is not a call for inactive adults to cut their current intake — only a suggestion that many may not need to keep adding more.

Leucine's Contradictory Findings and the Review's Disclosed Ties

Not every strand of evidence in the review points the same direction. On leucine, one of the amino acids the authors flag as a driver of growth-signaling pathways, the underlying research is split. News-Medical's account of the paper notes that Lamming's own mouse work found leucine restriction increased fat mass, while other research groups found the opposite — that leucine restriction reduced fat mass and improved glucose control. Human leucine supplementation, the same source notes, increases muscle protein synthesis without improving muscle function. The review does not reconcile this contradiction; it presents both findings as open questions. Readers should also weigh a disclosed financial detail: Lamming serves on the scientific advisory board of Aeovian Pharmaceuticals, a company developing mTOR inhibitors, a drug class that acts on nutrient-sensing pathways closely related to those discussed in the review.

The takeaway isn't that protein is harmful. It's narrower: the review argues protein needs scale with activity level, not just age, and that sedentary adults chasing the newest guidance may be optimizing for a benefit — muscle-building headroom — they aren't using. Where the evidence genuinely diverges, as with leucine, the review says so rather than picking a side.